Australia pain management drugs market is anticipated to grow at a CAGR of XX% from 2025 to 2030.
Pain management drugs are majorly used in treating short-term acute and chronic pain and with the growing geriatric population in Australia, the demand for such drugs is anticipated to pick up pace. According to the National Health Survey (NHS) 2022 conducted by the Australian Bureau of Statistics, nearly 22.3% of Australians aged between 65 to 74 years reported poor health, and the percentage share reached 31.3% for people aged over 75 years. Old age is more prone to chronic pain and with such constant health fluctuation, the scale of medicine consumption for pain management is anticipated to show progression.
Likewise, the prevalence rate of rheumatoid arthritis in Australia is also showing progression, for instance, according to Arthritis Australia, nearly 4.11 million Australians are suffering from arthritis, and by 2050 the figure is expected to grow to 5.39 million. The same source also stated that rheumatoid arthritis and musculoskeletal conditions constitute 12.7% of the total disease burden in Australia and 20% of the total arthritis patients require assistance in daily activity.
Besides musculoskeletal issues dealing with chronic disease prevalence inclusive of diabetes, cancer, and cardiac disease in Australia have also become a major concern for people, and with the high number of cases reported the demand for medication to suppress pain in such conditions is also expected to grow. Moreover, the level of surgical procedures in the country is growing constantly which is attributable to the growing emergency medical conditions.
According to the Australian Institute of Health and Welfare, in 2023 the number of patients admitted for elective surgery reached 778,500 which marked a 5.8% growth over the number of admissions in 2022. With such admissions, the demand for medication used post-operations will also show simultaneous growth thereby paving the way for future market expansion for pain management drugs in Australia. Additional factors like favorable government policies to bolster healthcare access followed by strategic investments by key market players to expand their operations have also provided new growth prospects.
Australia Pain Management Drug Market Segmentation